Abstract
Zonisamide is effective in the preventive therapy of chronic migraine
Highlights
Dear Colleagues Thank you for attending the independent satellite symposium entitled ‘Heralding a new era of episodic, chronic and refractory migraine management’ at the 12th European Headache Federation (EHF) Congress, which we hope you found engaging and educational
Professor Edvinsson questioned how migraine could be controlled and explained that the trigeminovascular system is thought to comprise neurons located in the trigeminal ganglion that innervate the cerebral vasculature including the dura mater.[7]. He noted that this system appears to be a key regulator of several vasoactive neuropeptides that are associated with neurogenic inflammation, including calcitonin gene-related peptide (CGRP), which may modulate pain transmission and vascular tone, making them an important target in the management of migraine
Professor Edvinsson highlighted that sumatriptan (3%), CGRP blockers (2%), and antibodies (
Summary
Dear Colleagues Thank you for attending the independent satellite symposium entitled ‘Heralding a new era of episodic, chronic and refractory migraine management’ at the 12th European Headache Federation (EHF) Congress, which we hope you found engaging and educational. Florence provided an excellent host city for this conference, bringing together emerging doctors, neurologists, and general practitioners to work towards a shared goal: to increase awareness of headache disorders and improve the quality of life of those affected by them. The symposium discussed advances in the pathophysiology of migraine, which included new and emerging therapeutic options for patients with episodic, chronic, and refractory migraine, and their role in reducing the burden of this debilitating condition. We hope that by sharing expert experience and perspectives, we have helped you to navigate the complexities of migraine and provided you with knowledge that you will be able to seamlessly apply to your own clinical practice.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
